About Xiel
Xiel is a Healthcare company based in United Kingdom founded in 2019, and was acquired by MIS Healthcare in February 2025. Specialist nuclear medicine and radiotherapy solutions are distributed. It operates on a Reseller / Distribution model. Xiel offers products and services including Nuclear Medicine Solutions, Radiotherapy Solutions, and Diagnostic Imaging Solutions. Its focus areas include Medical Devices and Diagnostic and Therapeutic Equipment. Its legal entity is Xiel Limited. Its competitors include CNX Therapeutics, Bartec Technologies and SPL Pharma.
Company details
Xiel Limited is involved in the distribution of specialized medical technologies, focusing on nuclear medicine, radiotherapy, and diagnostic imaging solutions. The company operates in the UK and Ireland, partnering with global manufacturers to supply hospitals, universities, research institutes, and private companies. Their expertise lies in understanding the structure of UK healthcare systems, ensuring tailored solutions for nuclear medicine and radiotherapy departments. Innovative products are brought to market through a deep commitment to customer service and efficiency improvements.
- Headquarters Somerset, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website xiel.co.uk
- Social LinkedIn
- Acquired by MIS Healthcare (Feb 2025)
- Legal Name Xiel Limited
- Investors
- Acquired byMIS Healthcare
(Feb 2025)
Products & Services of Xiel
Xiel offers a comprehensive portfolio of products and services, including Nuclear Medicine Solutions, Radiotherapy Solutions, and Diagnostic Imaging Solutions.
Solutions for nuclear medicine are distributed to healthcare providers.
Radiotherapy solutions are provided to hospitals and clinics.
Diagnostic imaging products are supplied to medical facilities.
Investors in Xiel
Xiel has secured backing from 1 investor. Prominent investors backing the company include MIS Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Leading medical imaging solutions provider and service expert | 1997 | mishealthcare.co.uk | London, United Kingdom |
Investor details for Xiel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Xiel
2 dated milestones of Xiel across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Xiel is founded.
- Exit Acquired by MIS Healthcare.
Competitors of Xiel
Xiel has 3 listed competitors in our database. They include CNX Therapeutics, Bartec Technologies and SPL Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cnx-therapeutics.com | 2021 | London, United Kingdom | Distributor of specialty drugs | |||
| bartectechnologies.com | 1998 | Farnborough, United Kingdom | Mediso: Advanced medical imaging systems and radioactive sources | |||
| splpharma.co.uk | 2016 | London, United Kingdom | International distribution of specialty medicines and pharmaceutical market access services. |
Detailed competitors of Xiel
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Xiel
The website of Xiel (xiel.co.uk) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 48.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Xiel
Complete news archive for Xiel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xiel
Xiel was founded in 2019.
Xiel is headquartered in United Kingdom. It is registered at Somerset, United Kingdom.
Xiel Limited is involved in the distribution of specialized medical technologies, focusing on nuclear medicine, radiotherapy, and diagnostic imaging solutions. The company operates in the UK and Ireland, partnering with global manufacturers to supply hospitals, universities, research institutes, and private companies. Their expertise lies in understanding the structure of UK healthcare systems, ensuring tailored solutions for nuclear medicine and radiotherapy departments. Innovative products are brought to market through a deep commitment to customer service and efficiency improvements.
Xiel's top competitors include CNX Therapeutics, Bartec Technologies and SPL Pharma.
Xiel offers Nuclear Medicine Solutions, Radiotherapy Solutions, and Diagnostic Imaging Solutions.
Xiel has 1 investor. Key investors include MIS Healthcare.
Xiel operates through Xiel Limited.
Yes. Xiel was acquired by MIS Healthcare in February 2025.